ESTHMR إستثمر

Minapharm Pharmaceuticals MIPH

مينا فارم للأدوية والصناعات الكيماوية

Health Care & PharmaceuticalsEgyptian Exchange

798.89 EGP

-1.37%

Close of Thu 12 Nov 2026

Market value
EGP 9.17bn
Highest and lowest close in a year
310.35 – 941.03
Shares traded in the session
2,557
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Established in October 1986 and based in Cairo, Egypt, Minapharm Pharmaceuticals is a pharmaceuticals, biotechnology, and life sciences company focusing on pharmaceuticals. Listed on the Egyptian Exchange since January 2004, it is controlled by TRIQUEAR B.V, which held 83.3151% as of June 2026. Its subsidiaries include ProBioGen AG (99.19%), Minapharm for Trade and Distribution (95.0%), Migentra Egypt Healthcare Transforming Medicines (75.01%), and MiGenTra- GmbH (49.0%).

Its record at the exchange

Minapharm Pharmaceuticals has 582 filings from 2010 to 2026, peaking in 2022 with 58 filings. Trading was suspended and resumed 9 times. Across 63 reported periods from 2013 to 2026, 3 were loss-making. Its highest full-year net result was 631 million EGP in FY 2022, while its lowest was 22 million EGP in FY 2023. On 2026-02-03, it executed its first capital decrease in 11 years via treasury stock cancellation.

Its latest filings at the exchange

  1. Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Disclosure Form for the Board of Directors and Shareholders' Structure
  2. Auditor or accountsMinapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report
  3. ResultsMinapharm Pharmaceuticals (MIPH.CA) Reports 6 Months Consolidated Results
  4. Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Minutes of the BoD Meeting
  5. Board decisionsMinapharm Pharmaceuticals (MIPH.CA) - Minutes of the Board of Directors' Meeting
  6. ResultsMinapharm Pharmaceuticals (MIPH.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 30/06/2026
  7. Release from Minapharm Pharmaceuticals (MIPH.CA)
  8. Auditor or accountsMinapharm Pharmaceuticals (MIPH.CA) - Company's Response to the Auditor's Report

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Insider / Board Bought983 (less than 0.01% of the company)Bulletin ↗
  2. Insider / Board Bought5,306 (0.05% of the company)Bulletin ↗
  3. Insider / Board Sold10,790 (0.09% of the company)Bulletin ↗
  4. Insider / Board Bought10,790 (0.09% of the company)Bulletin ↗
  5. Insider / Board Sold11,000 (0.09% of the company)Bulletin ↗
  6. Insider / Board Bought11,000 (0.09% of the company)Bulletin ↗
  7. Insider / Board Sold1 (less than 0.01% of the company)Bulletin ↗
  8. Insider / Board Bought1,647 (0.01% of the company)Bulletin ↗
  9. Insider / Board Bought1 (less than 0.01% of the company)Bulletin ↗
  10. Insider / Board Bought7,220 (0.06% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 15 Nov 2026.